169 related articles for article (PubMed ID: 20970346)
1. Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membered ring nitrogen analogue of kotalanol and its de-O-sulfonated derivative.
Mohan S; Sim L; Rose DR; Pinto BM
Bioorg Med Chem; 2010 Nov; 18(22):7794-8. PubMed ID: 20970346
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of heteroanalogues of kotalanol and de-O-sulfonated kotalanol.
Mohan S; Jayakanthan K; Nasi R; Kuntz DA; Rose DR; Pinto BM
Org Lett; 2010 Mar; 12(5):1088-91. PubMed ID: 20143790
[TBL] [Abstract][Full Text] [Related]
3. Studies directed toward the stereochemical structure determination of the naturally occurring glucosidase inhibitor, kotalanol: synthesis and inhibitory activities against human maltase glucoamylase of seven-carbon, chain-extended homologues of salacinol.
Nasi R; Patrick BO; Sim L; Rose DR; Pinto BM
J Org Chem; 2008 Aug; 73(16):6172-81. PubMed ID: 18651773
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a biologically active isomer of kotalanol, a naturally occurring glucosidase inhibitor.
Eskandari R; Jayakanthan K; Kuntz DA; Rose DR; Pinto BM
Bioorg Med Chem; 2010 Apr; 18(8):2829-35. PubMed ID: 20363144
[TBL] [Abstract][Full Text] [Related]
5. New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata.
Sim L; Jayakanthan K; Mohan S; Nasi R; Johnston BD; Pinto BM; Rose DR
Biochemistry; 2010 Jan; 49(3):443-51. PubMed ID: 20039683
[TBL] [Abstract][Full Text] [Related]
6. Structure proof and synthesis of kotalanol and de-O-sulfonated kotalanol, glycosidase inhibitors isolated from an herbal remedy for the treatment of type-2 diabetes.
Jayakanthan K; Mohan S; Pinto BM
J Am Chem Soc; 2009 Apr; 131(15):5621-6. PubMed ID: 19331410
[TBL] [Abstract][Full Text] [Related]
7. Towards the elusive structure of kotalanol, a naturally occurring glucosidase inhibitor.
Mohan S; Pinto BM
Nat Prod Rep; 2010 Apr; 27(4):481-8. PubMed ID: 20336233
[TBL] [Abstract][Full Text] [Related]
8. New chain-extended analogues of salacinol and blintol and their glycosidase inhibitory activities. Mapping the active-site requirements of human maltase glucoamylase.
Nasi R; Sim L; Rose DR; Pinto BM
J Org Chem; 2007 Jan; 72(1):180-6. PubMed ID: 17194097
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives.
Rossi EJ; Sim L; Kuntz DA; Hahn D; Johnston BD; Ghavami A; Szczepina MG; Kumar NS; Sterchi EE; Nichols BL; Pinto BM; Rose DR
FEBS J; 2006 Jun; 273(12):2673-83. PubMed ID: 16817895
[TBL] [Abstract][Full Text] [Related]
10. Role of the side chain stereochemistry in the α-glucosidase inhibitory activity of kotalanol, a potent natural α-glucosidase inhibitor.
Xie W; Tanabe G; Matsuoka K; Amer MF; Minematsu T; Wu X; Yoshikawa M; Muraoka O
Bioorg Med Chem; 2011 Apr; 19(7):2252-62. PubMed ID: 21420866
[TBL] [Abstract][Full Text] [Related]
11. Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase.
Jones K; Sim L; Mohan S; Kumarasamy J; Liu H; Avery S; Naim HY; Quezada-Calvillo R; Nichols BL; Pinto BM; Rose DR
Bioorg Med Chem; 2011 Jul; 19(13):3929-34. PubMed ID: 21669536
[TBL] [Abstract][Full Text] [Related]
12. Probing the active-site requirements of human intestinal N-terminal maltase glucoamylase: the effect of replacing the sulfate moiety by a methyl ether in ponkoranol, a naturally occurring α-glucosidase inhibitor.
Eskandari R; Jones K; Rose DR; Pinto BM
Bioorg Med Chem Lett; 2010 Oct; 20(19):5686-9. PubMed ID: 20801033
[TBL] [Abstract][Full Text] [Related]
13. New synthetic routes to chain-extended selenium, sulfur, and nitrogen analogues of the naturally occurring glucosidase inhibitor salacinol and their inhibitory activities against recombinant human maltase glucoamylase.
Liu H; Nasi R; Jayakanthan K; Sim L; Heipel H; Rose DR; Pinto BM
J Org Chem; 2007 Aug; 72(17):6562-72. PubMed ID: 17658854
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents.
Mohan S; Eskandari R; Pinto BM
Acc Chem Res; 2014 Jan; 47(1):211-25. PubMed ID: 23964564
[TBL] [Abstract][Full Text] [Related]
15. Biological evaluation of de-O-sulfonated analogs of salacinol, the role of sulfate anion in the side chain on the alpha-glucosidase inhibitory activity.
Tanabe G; Yoshikai K; Hatanaka T; Yamamoto M; Shao Y; Minematsu T; Muraoka O; Wang T; Matsuda H; Yoshikawa M
Bioorg Med Chem; 2007 Jun; 15(11):3926-37. PubMed ID: 17416527
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of analogues of salacinol containing a carboxylate inner salt and their inhibitory activities against human maltase glucoamylase.
Chen W; Sim L; Rose DR; Pinto BM
Carbohydr Res; 2007 Sep; 342(12-13):1661-7. PubMed ID: 17597595
[TBL] [Abstract][Full Text] [Related]
17. Potent glucosidase inhibitors: de-O-sulfonated ponkoranol and its stereoisomer.
Eskandari R; Kuntz DA; Rose DR; Pinto BM
Org Lett; 2010 Apr; 12(7):1632-5. PubMed ID: 20218632
[TBL] [Abstract][Full Text] [Related]
18. A new class of glucosidase inhibitor: analogues of the naturally occurring glucosidase inhibitor salacinol with different ring heteroatom substituents and acyclic chain extension.
Liu H; Sim L; Rose DR; Pinto BM
J Org Chem; 2006 Apr; 71(8):3007-13. PubMed ID: 16599595
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a salacinol analogue and its alpha-glucosidase inhibitory activity.
Shao Y; Osamu M; Kazuya Y; Yoshiharu M; Eriko Y; Toshie M; Genzoh T; Hisashi M; Masayuki Y; You QD
Yao Xue Xue Bao; 2006 Jul; 41(7):647-53. PubMed ID: 17007358
[TBL] [Abstract][Full Text] [Related]
20. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity.
Sim L; Quezada-Calvillo R; Sterchi EE; Nichols BL; Rose DR
J Mol Biol; 2008 Jan; 375(3):782-92. PubMed ID: 18036614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]